The costs and health effects of treating typhoid might soon increase dramatically, since the bacteria that causes typhoid is becoming increasingly resistant to the most effective oral antimicrobial drugs, thus requiring treatment with more expensive intravenous antibiotics which may result in more frequent hospitalizations for suspected typhoid cases.
Full Citation:
Andrews JR, Baker S, Marks F et al.. 2019. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. Lancet Infectious Disease. 19(1).
Title of Article: Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance
Author(s): Andrews JR, Baker S, Marks F et al.
Publication Year: 2019
Publication Name: Lancet Infectious Disease
Publication Volume: 19(1)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/30170987/
DOI (Digital Object Identifier): 10.1016/S1473-3099(18)30350-5